CapriCare
clinical studies / Randomised double-blind comparison of the growth in infants receiving goat milk formula versus cow milk formula.

Randomised double-blind comparison of the growth in infants receiving goat milk formula versus cow milk formula.

Grant et al. 2005 (Auckland, New Zealand)

Overview

While goat milk was widely consumed in many countries, the use of goat milk formula (fortified to meet infant requirements) was relatively new in the early 2000s. This was the first clinical study to show that whole goat milk formula (WGF™) is a safe and effective alternative to cow milk formula (CMF) for healthy infants. This growth and tolerance study demonstrated the suitability of WGF™ for parents and healthcare professionals.

Methods

Principal Investigator: Professor Cameron Grant, Paediatrics Child & Youth Health, New Zealand

Ethics approval: New Zealand Ministry of Health

Formulations: DGC WGF™ and commercially available CMF

{space}

This double-blind, randomised controlled trial was conducted in Auckland, New Zealand. Healthy term infants whose mothers chose not to breastfeed were randomly assigned to WGF™ (n=36) or CMF (n=36) within 72 hours of birth. They exclusively consumed the assigned formula until they were six months old. Caregivers and researchers were unaware of which formula was given.

{space}

Growth measurements (infant weight, length, and head circumference) were taken regularly. Tolerance to the formula was determined using parental diaries of infant bowel habits and crying patterns, and adverse events were monitored (a requirement of all clinical trials). Weaning foods were introduced after four months, and adherence to the study protocol was ensured through regular visits.

Key findings

This study established that the growth of infants fed WGF™ was similar to that of infants fed CMF, with no significant differences in weight, length, or head circumference.* A breastfed reference group was not included in the study. New Zealand growth data for breast-fed infants was sourced from a previous New Zealand study. The comparison found that weight of the infants on WGF™ and CMF did not differ from the breastfed infant reference data.

This study established that the WGF™ was well tolerated and safe. WGF™-fed infants had slightly more frequent bowel movements^†^ but showed no differences in bowel consistency or behaviours like crying or settling.^‡^ There were no differences in adverse events between the formula-fed groups.

Conclusion

For the first time, this study demonstrated that WGF™ is a safe and effective food supporting infants’ healthy growth and well-being.


Reference

{small}CI: confidence interval; CMF: cow milk formula; WGF™: whole goat milk formula.{/small}

^*^Average weight gain: +309 g, 95% CI −49 to +668, P=0.09; Average increase in length: 0.8 cm, 95% CI −0.2 to +1.8, P=0.09; Average change in head circumference: +0.3 cm, 95% CI −0.2 to +0.8, P=0.23.
^†^Per day WGF™ 2.4 vs CMF 1.7, P=0.01. This was not excessive nor associated with any other difference in stool consistency. It may relate to differences in digestibility, for example, GMF forms a softer curd than CMF.
^‡^WGF™ vs CMF; Runny bowel movements at any visit: 5 vs 6, P=0.82; Hard bowel movements at any visit: 4 vs 2, P=0.35; Crying for 3–6 hours per day at any visit: 3 vs 7, P=0.19; Easy to settle at all visits: 17 vs 15, P=0.48.
Grant et al. {italic}J Paediatr Child Health{/italic}. 2005; 41(11):564-568


Share this article:


Manufactured in New Zealand by:

Dairy Goat Co-operative (N.Z.) Limited.
18 Gallagher Dr, Hamilton,
New Zealand.

Healthcare Professionals

Are you a healthcare professional looking for more details about our WGF™ Capricare®? Click below to find out more about our product, clinical trials and results.

Capricare® 2026 ©Capricare® and Dairy Goat Co-operative® is a registered trade mark of Dairy Goat Co-operative (N.Z.) Limited.